Individualized conditional survival nomograms for stage I-III early onset colorectal cancer patients

被引:3
作者
Chen, Min [1 ,2 ]
Chen, Ting [1 ]
机构
[1] Nanjing Univ Chinese Med, Changshu Hosp, Dept Gen Surg, Changshu, Peoples R China
[2] Nanjing Univ Chinese Med, Changshu Hosp, Dept Gen Surg, Changshu 215500, Peoples R China
关键词
early onset colorectal cancer; conditional survival; nomogram; overall survival; cancer-specific survival;
D O I
10.1093/jjco/hyac169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Conditional survival accounts for the time already survived after surgery and provides additional survival information. The aim was to assess conditional survival in stages I-III early onset colorectal cancer patients and to create nomograms predicting the conditional overall survival and cancer-specific survival after surgery. Methods A total of 7058 patients who underwent surgical resection of early onset colorectal cancer were identified from surveillance, epidemiology and end results database. The formula used for conditional survival calculation was conditional survival((x|y)) = S(x + y)/S-(x), where S-(x) represents the survival at x years. Conditional survival nomograms were then developed to predict the 5-year conditional overall survival and cancer-specific survival. Results The 5-year overall survival and cancer-specific survival after surgery increases gradually with additional survival time. Race, tumour site, grade, histology, T stage, N stage, lymph node ratio, preoperative carcinoma embryonic antigen level and perineural invasion status were independent predictors of cancer-specific survival, while age and sex were another two independent risk factors for overall survival. The nomograms based on these factors were successfully developed to predict 5-year overall survival and cancer-specific survival given 1-4 years already survived. Conclusion The probability of achieving postoperative 5-year overall survival and cancer-specific survival for early onset colorectal cancer increases gradually with additional time survived. The developed nomograms are fairly valuable and informative in facilitating clinical treatment and follow-up schemes. No previous studies have attempted to analyse the conditional survival for early onset colorectal cancer patients. We successfully developed nomograms to predict conditional survival with considerable prognostic accuracy for these patients.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 20 条
  • [1] Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living ≥24 Months A Single Institutional Study
    Ali, Nadia D.
    Donohue, Kristen
    Zandieh, Shadi
    Chen, Chunxia
    Moore, Dirk
    Poplin, Elizabeth
    Shah, Mihir M.
    Nosher, John
    Gui, Bin
    Jabbour, Salma K.
    Spencer, Kristen
    Carpizo, Darren R.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (06): : 512 - 518
  • [2] Perineural invasion is associated with poor prognosis of colorectal cancer: a retrospective cohort study
    Cao, Yinghao
    Deng, Shenghe
    Yan, Lizhao
    Gu, Junnan
    Li, Jiang
    Wu, Ke
    Cai, Kailin
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (06) : 1067 - 1075
  • [3] Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study
    Fernandez, Laura M.
    Sao Juliao, Guilherme P.
    Figueiredo, Nuno L.
    Beets, Geerard L.
    van der Valk, Maxime J. M.
    Bahadoer, Renu R.
    Hilling, Denise E.
    Kranenbarg, Elma Meershoek-Klein
    Roodvoets, Annet G. H.
    Renehan, Andrew G.
    van de Velde, Cornelis J. H.
    Habr-Gama, Angelita
    Perez, Rodrigo O.
    [J]. LANCET ONCOLOGY, 2021, 22 (01) : 43 - 50
  • [4] Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin
    Fontana, Elisa
    Meyers, Jeff
    Sobrero, Alberto
    Iveson, Timothy
    Shields, Anthony F.
    Taieb, Julien
    Yoshino, Takayuki
    Souglakos, Ioannis
    Smyth, Elizabeth C.
    Lordick, Florian
    Moehler, Markus
    Giraut, Anne
    Harkin, Andrea
    Labianca, Roberto
    Meyerhardt, Jeffrey
    Andre, Thierry
    Boukovinas, Ioannis
    Lonardi, Sara
    Saunders, Mark
    Vernerey, Dewi
    Oki, Eiji
    Georgoulias, Vassilis
    Ben-Aharon, Irit
    Shi, Qian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (36) : 4009 - +
  • [5] Conditional survival estimates for cancer patients
    Haydu, Lauren E.
    Scolyer, Richard A.
    Thompson, John F.
    [J]. ONCOTARGET, 2017, 8 (49) : 84639 - 84640
  • [6] Statistical Methods for Conditional Survival Analysis
    Jung, Sin-Ho
    Lee, Ho Yun
    Chow, Shein-Chung
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (05) : 927 - 938
  • [7] Conditional Probability of Survival After Neoadjuvant Chemoradiation and Proctectomy for Rectal Cancer: What Matters and When
    Karagkounis, Georgios
    Liska, David
    Kalady, Matthew F.
    [J]. DISEASES OF THE COLON & RECTUM, 2019, 62 (01) : 33 - 39
  • [8] Personalizing prognostic prediction in early-onset Colorectal Cancer
    Liu, Jian
    Liu, Zhengru
    Li, Jiao
    Tian, Shan
    Dong, Weiguo
    [J]. JOURNAL OF CANCER, 2020, 11 (22): : 6727 - 6736
  • [9] Metastatic lymph node ratio as a better prognostic tool than the TNM system in colorectal cancer
    Macedo, Filipa
    Sequeira, Hugo
    Ladeira, Katia
    Bonito, Nuno
    Viana, Charlene
    Martins, Sandra
    [J]. FUTURE ONCOLOGY, 2021, 17 (12) : 1519 - 1532
  • [10] Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes
    Mahar, Alyson L.
    Compton, Carolyn
    Halabi, Susan
    Hess, Kenneth R.
    Weiser, Martin R.
    Groome, Patti A.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (08) : 969 - 982